Coronavirus (COVID-19) mRNA vaccine BNT162b2 Pfizer/BioNTech: national protocol

Protocol guidance for the COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech.

This document is part of a collection


Supporting documents

COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech Vaccine National Protocol

COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech Vaccine National Protocol - Version 3.2

COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech Vaccine National Protocol - Version 3.4

Back to top